US Trade Representative Removes Host Of Devices, Parts From China Tariff List
Executive Summary
The US Trade Representative’s Office has agreed to remove a group of medtech products and components from its list of those imported from China that initially would be tariffed at 25%, making its exclusion-from-tariffs decision retroactive one year, and extending the exclusion to 9 July 2020.
You may also be interested in...
Industry Advocacy Group Goes Global After Device Tax Repeal
After an eleventh-hour win last year that saw Congress repeal the medical device excise tax, AdvaMed is going more global. CEO Scott Whitaker sat down with Medtech Insight for a lengthy chat about what the lobby group will focus on in 2020, including reimbursement challenges, the upcoming medical device user-fee negotiations, and negotiations with governments that are key to the industry ecosystem.
Industry Groups Oppose 25% China Tariffs Still In Play On High-End Medical Equipment, Hospital Products
Industry groups expressed strong opposition at the end of June to US-planned 25% tariffs on China goods – including billions of dollars in medtech and hospital supplies – by the US Trade Representative’s Office, despite ongoing talks between President Trump and Chinese President Xi Jinping to deal with US-China trade tensions.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.